Prevalence of Epilepsy and Epileptic Seizures in 10-Year-Old Children: Results from the Metropolitan Atlanta Developmental Disabilities Study
Article first published online: 3 AUG 2005
Volume 36, Issue 9, pages 866–872, September 1995
How to Cite
Murphy, C. C., Trevathan, E. and Yeargin-Allsopp, M. (1995), Prevalence of Epilepsy and Epileptic Seizures in 10-Year-Old Children: Results from the Metropolitan Atlanta Developmental Disabilities Study. Epilepsia, 36: 866–872. doi: 10.1111/j.1528-1157.1995.tb01629.x
- Issue published online: 3 AUG 2005
- Article first published online: 3 AUG 2005
- Received November 15, 1994; revision accepted February 13, 1995.
- Epilepsy–Childhood epilepsy–Seizures–Epidemiology–Prevalence
Summary: With reported prevalence rates of 4–9 cases per 1,000 children, childhood epilepsy is a major public health concern. Reported prevalence rates vary, mainly because researchers often use different epilepsy definitions. In addition, total prevalence may be underestimated if incomplete case-ascertainment methods are used. We used a multiple-source case-ascertainment method that included obtaining information from electro-encephalogram laboratories to estimate the prevalence of epilepsy and to classify seizure types among 10–year-old children. In the metropolitan Atlanta (GA, U.S.A.) area, we found a lifetime prevalence of childhood epilepsy of 6 per 1,000 (95% confidence interval, 5. 5–6. 5) 10-year-old children. However, using capture-recapture analysis, this prevalence may be as high as 7. 7 per 1,000. Proportionately more boys than girls had epilepsy. The prevalence did not vary appreciably by race. Partial seizures, including secondarily generalized seizures, were the most common seizure type (58%). Of children with epilepsy, 35% had another developmental disability (mental retardation, cerebral palsy, visual impairment, or hearing impairment). An accurate estimate of the public health burden of childhood epilepsy and determination of possible risk factors for idiopathic epilepsy both depend on conducting complete community-based case ascertainment and obtaining detailed clinical data.